Cargando…

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy

Cancer stem cells (CSCs) are subpopulations of cells with stem cell characteristics that produce both cancerous and non-tumorigenic cells in tumor tissues. The literature reports that CSCs are closely related to the development of hepatocellular carcinoma (HCC) and promote the malignant features of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yafei, Zhang, Jigang, Zhang, Xue, Zhou, Heming, Liu, Gaolin, Li, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068598/ https://www.ncbi.nlm.nih.gov/pubmed/32210805 http://dx.doi.org/10.3389/fphar.2020.00198

Ejemplares similares

Autophagy, an accomplice or antagonist of drug resistance in HCC?
por: Wu, Yafei, et al.
Publicado: (2021)

Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy
por: Qin, Weiwei, et al.
Publicado: (2017)

Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy
por: Wang, Shi-Bing, et al.
Publicado: (2019)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Wu, Le, et al.
Publicado: (2021)

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
por: La-Beck, Ninh M., et al.
Publicado: (2019)

Mechanism of sorafenib resistance associated with ferroptosis in HCC
por: Guo, Lingling, et al.
Publicado: (2023)

Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022)

Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies
por: Keyvani, Vahideh, et al.
Publicado: (2022)

Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
por: Wang, Xing, et al.
Publicado: (2021)

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023)

Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)

Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells
por: Wang, Jinheng, et al.
Publicado: (2017)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy
por: Dong, Liangbo, et al.
Publicado: (2023)

Natural Product Target Network Reveals Potential for Cancer Combination Therapies
por: Chamberlin, Steven R., et al.
Publicado: (2019)

Targeting the Integrated Stress Response in Cancer Therapy
por: Tian, Xiaobing, et al.
Publicado: (2021)

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
por: Liu, Xuan, et al.
Publicado: (2022)

Osimertinib making a breakthrough in lung cancer targeted therapy
por: Zhang, Haijun
Publicado: (2016)

Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
por: Yang, Hongxing, et al.
Publicado: (2022)

Imatinib: A Breakthrough of Targeted Therapy in Cancer
por: Iqbal, Nida, et al.
Publicado: (2014)

Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
por: Lei, Jin, et al.
Publicado: (2022)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021)

Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism
por: Luo, Maocai, et al.
Publicado: (2023)

Traditional Tibetan Medicine in Cancer Therapy by Targeting Apoptosis Pathways
por: Tang, Ce, et al.
Publicado: (2020)

miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway
por: Xu, Dan-dan, et al.
Publicado: (2016)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management
por: Lin, Yan, et al.
Publicado: (2022)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
por: Liu, Yayun, et al.
Publicado: (2023)

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways
por: Lin, Si, et al.
Publicado: (2022)

PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC
por: Wang, Xiao, et al.
Publicado: (2020)

Exosomes As Potential Biomarkers and Targeted Therapy in Colorectal Cancer: A Mini-Review
por: Hon, Kha Wai, et al.
Publicado: (2017)

P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology
por: Stokes, Leanne, et al.
Publicado: (2017)

Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
por: Cui, Yuting, et al.
Publicado: (2022)

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
por: Zhang, Xue, et al.
Publicado: (2019)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022)

Crizotinib: A Breakthrough for Targeted Therapies in Lung Cancer
por: Kwon, Jennifer, et al.
Publicado: (2012)

N(6)-Methyladenosine: A Potential Breakthrough for Human Cancer
por: Liu, Lina, et al.
Publicado: (2019)

Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC
por: Wang, Xiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mrnsihaoh4e8ajor2lvgnnqgjo